Incidence of adverse events in iron‐deficient pregnant women and surgical patients undergoing intravenous iron treatment with ferric isomaltose or ferric carboxymaltose: A systematic review

Documenti analoghi

• Sex differences in surgical patients with preoperative iron deficiency anemia
  di: Una E. Choi, et al.
  Pubblicazione: (2026)
• Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency
  di: S. K. Piechnik, et al.
  Pubblicazione: (2024)
• Revisiting a “new” yet “old” approach: Reticulocyte hemoglobin and related hematological indices for iron deficiency screening for patient blood management
  di: Jesse Qiao, et al.
  Pubblicazione: (2025)
• Modernizing iron screening: The case for reticulocyte hemoglobin
  di: Jesse Qiao, et al.
  Pubblicazione: (2025)
• Impact of a single blood donation on hemoglobin mass, iron stores, and maximum oxygen uptake in pre‐menopausal women—A pilot study
  di: Nadine B. Wachsmuth, et al.
  Pubblicazione: (2024)